These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 23625864

  • 1. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS, Hsieh SC, Chang WY, Wu GH, Huang HS, Lee C.
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [Abstract] [Full Text] [Related]

  • 2. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
    Riou França L, Vidal C, Bourechak N, Jeunne PL, Deville GS, Massol J.
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799
    [Abstract] [Full Text] [Related]

  • 3. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM, Ou HT, Yang YK.
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [Abstract] [Full Text] [Related]

  • 4. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA, Cline RR.
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [Abstract] [Full Text] [Related]

  • 5. Physician characteristics and prescription drug use during pregnancy: a population-based study.
    Weng SS, Chen YH, Lin CC, Keller JJ, Wang IT, Lin HC.
    Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810
    [Abstract] [Full Text] [Related]

  • 6. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY.
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
    [Abstract] [Full Text] [Related]

  • 7. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B, Zoëga H, Furu K, Korhonen M, Hallas J, Nørgaard M, Almarsdottir A, Andersen M, Andersson Sundell K, Bergman U, Helin-Salmivaara A, Hoffmann M, Kieler H, Martikainen J, Mortensen M, Petzold M, Wallach-Kildemoes H, Wallin C, Sørensen H.
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [Abstract] [Full Text] [Related]

  • 8. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM, Yang YH, Hsieh CR.
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [Abstract] [Full Text] [Related]

  • 9. [Generic substitution in primary care in 2011: differences according to pharmacological classes?].
    Sommet A, Georgel B, Poutrain JC, Oustric S, Bourrel R, Montastruc JL, Birebent J.
    Rev Epidemiol Sante Publique; 2013 Dec; 61(6):539-44. PubMed ID: 24211149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
    Pichetti S, Sermet C, Godman B, Campbell SM, Gustafsson LL.
    Appl Health Econ Health Policy; 2013 Jun; 11(3):205-18. PubMed ID: 23609765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J, Seeger JD, Donneyong M, Gagne JJ, Avorn J, Kesselheim AS.
    JAMA Intern Med; 2016 Sep 01; 176(9):1317-23. PubMed ID: 27367749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T, Smith MA, Camp PG, Carleton BC.
    Pharmacoepidemiol Drug Saf; 2013 Jul 01; 22(7):744-51. PubMed ID: 23559540
    [Abstract] [Full Text] [Related]

  • 16. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
    Hsiao FY, Tsai YW, Huang WF.
    Clin Ther; 2009 Nov 01; 31(11):2618-27. PubMed ID: 20110006
    [Abstract] [Full Text] [Related]

  • 17. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
    Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD.
    Pharmacoepidemiol Drug Saf; 2008 Jun 01; 17(6):609-19. PubMed ID: 18481335
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection.
    Lin YS, Jan IS, Cheng SH.
    Pharmacoepidemiol Drug Saf; 2017 Mar 01; 26(3):301-309. PubMed ID: 27862588
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Hsu CW, Lee SY, Wang LJ.
    Schizophr Res; 2018 Mar 01; 193():107-113. PubMed ID: 28629889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.